99 related articles for article (PubMed ID: 8687162)
1. Topographical immunohistochemical expression of bcl-2 protein in human liver lesions.
Skopelitou A; Hadjiyannakis M; Alexopoulou V; Krikoni O; Kamina S; Agnantis N
Anticancer Res; 1996; 16(2):975-8. PubMed ID: 8687162
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of bcl-2 protein in normal and pathological human liver.
Charlotte F; L'Herminé A; Martin N; Geleyn Y; Nollet M; Gaulard P; Zafrani ES
Am J Pathol; 1994 Mar; 144(3):460-5. PubMed ID: 8129031
[TBL] [Abstract][Full Text] [Related]
3. The Das-1 immunostain is useful for discriminating metastatic colon adenocarcinoma from cholangiocarcinoma and hepatocellular carcinoma.
Zimmerman RL; Das KM; Fogt F; Burke M; Murakata LA
Oncol Rep; 2002; 9(6):1369-72. PubMed ID: 12375050
[TBL] [Abstract][Full Text] [Related]
4. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
Abe N; Watanabe T; Izumisato Y; Suzuki Y; Masaki T; Mori T; Sugiyama M; Fusco A; Atomi Y
J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical evaluation of Bcl-2 gene family expression in liver of hepatitis C and cirrhotic patients: a novel mechanism to explain the high incidence of hepatocarcinoma in cirrhotics.
Frommel TO; Yong S; Zarling EJ
Am J Gastroenterol; 1999 Jan; 94(1):178-82. PubMed ID: 9934751
[TBL] [Abstract][Full Text] [Related]
6. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
Lau SK; Prakash S; Geller SA; Alsabeh R
Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
[TBL] [Abstract][Full Text] [Related]
7. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
Shiran MS; Isa MR; Sherina MS; Rampal L; Hairuszah I; Sabariah AR
Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
[TBL] [Abstract][Full Text] [Related]
8. [Anatomo-pathologic diagnostic interpretation of nodular hepatic lesions].
Chiaramondia M; Ceppa P; Baccini P; Badini A; Castellaneta A
Pathologica; 1993; 85(1100):687-99. PubMed ID: 8170717
[TBL] [Abstract][Full Text] [Related]
9. Primary vs metastatic hepatic carcinoma. An immunohistochemical study of 34 cases.
Fucich LF; Cheles MK; Thung SN; Gerber MA; Marrogi AJ
Arch Pathol Lab Med; 1994 Sep; 118(9):927-30. PubMed ID: 7521638
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices.
Ioachim EE; Malamou-Mitsi V; Kamina SA; Goussia AC; Agnantis NJ
Anticancer Res; 2000; 20(6B):4221-5. PubMed ID: 11205251
[TBL] [Abstract][Full Text] [Related]
11. [Determination on of C/EBP in human liver cancer, normal adult liver and various diseased liver tissues].
Xu LX
Zhonghua Zhong Liu Za Zhi; 1993 Sep; 15(5):332-4. PubMed ID: 8174474
[TBL] [Abstract][Full Text] [Related]
12. Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study.
Tsamandas AC; Thomopoulos K; Zolota V; Kourelis T; Karatzas T; Ravazoula P; Tepetes K; Petsas T; Karavias D; Karatza C; Bonikos DS; Gogos C
Mod Pathol; 2003 Dec; 16(12):1273-88. PubMed ID: 14681329
[TBL] [Abstract][Full Text] [Related]
13. Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver.
de Boer CJ; van Krieken JH; Janssen-van Rhijn CM; Litvinov SV
J Pathol; 1999 Jun; 188(2):201-6. PubMed ID: 10398165
[TBL] [Abstract][Full Text] [Related]
14. Characterization of apomucin expression in intrahepatic cholangiocarcinomas and their precursor lesions: an immunohistochemical study.
Sasaki M; Nakanuma Y; Kim YS
Hepatology; 1996 Nov; 24(5):1074-8. PubMed ID: 8903378
[TBL] [Abstract][Full Text] [Related]
15. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas.
Okamura N; Yoshida M; Shibuya A; Sugiura H; Okayasu I; Ohbu M
Pathol Int; 2005 Nov; 55(11):724-31. PubMed ID: 16271085
[TBL] [Abstract][Full Text] [Related]
16. Different proliferative patterns characterize different preinvasive breast lesions.
Viacava P; Naccarato AG; Bevilacqua G
J Pathol; 1999 Jul; 188(3):245-51. PubMed ID: 10419590
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactivity for c-erbB-2 oncopeptide in benign and malignant diseases of the liver.
Brunt EM; Swanson PE
Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S53-61. PubMed ID: 1374219
[TBL] [Abstract][Full Text] [Related]
18. The expression of antiapoptotic proteins Bcl-2, Bcl-X(L), and Mcl-1 in benign, dysplastic, and malignant biliary epithelium.
Okaro AC; Deery AR; Hutchins RR; Davidson BR
J Clin Pathol; 2001 Dec; 54(12):927-32. PubMed ID: 11729212
[TBL] [Abstract][Full Text] [Related]
19. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
20. Effect of preoperative transcatheter arterial chemoembolization on apoptosis of hepatocellular carcinoma cells.
Xiao E; Li D; Shen S; Zhou S; Tan L; Wang Y; Luo J; Wu Y; Tan C; Liu H; Zhu H
Chin Med J (Engl); 2003 Feb; 116(2):203-7. PubMed ID: 12775230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]